摘要
目的探讨沙培林联合碘化油乳剂在原发性肝癌治疗中的应用价值。方法对59例原发性肝癌患者分实验组及对照组,分别进行沙培林TACE治疗及常规TACE治疗,对术后反应及疗效进行对比分析。结果术后实验组在治疗效果、肝功能、生存率上优于对照组,副作用两组大致相同。结论沙培林碘化油乳剂免疫栓塞治疗中晚期肝癌是一种安全可行的治疗方法。
Objective To analyze the value of transarterial immunoembolization with an emulsion of streptococcal agent Sapylln and lipiodol in treating patients with hepatocellular carcinoma. Methods 59 patients with hepatocellular carcinoma were divided into two groups: test group and control group. Test group were cured with the streptococcal agent Sapylin and lipiodol, control group were cured with the common chemical drug and lipiodol. The differenceof the reaction and curative effect in the near future were studied. Results The effective of treatment, liver function and survivial rate of test group resembling those after transarterial chemoembolization were better than those of control group, the side effcet after treatemnt was the smae be-tween two groups. Conclusion It is a safe and feasible therapeutic modality that transarterial immunoembolization with an emulsion of streptococcal agent Sapylin and lipiodol in treating patients with hepatocellular carcinoma.
出处
《广州医药》
2008年第1期48-50,共3页
Guangzhou Medical Journal
基金
广东省社会发展领域科技计划项目
编号:73114